Results

X4 Pharmaceuticals Inc.

06/11/2021 | Press release | Distributed by Public on 06/11/2021 01:05

X4 Pharmaceuticals Announces Presentation of Positive Data from Ongoing Phase 1b Clinical Trial of Mavorixafor in Waldenström’s Macroglobulinemia at EHA 2021